Monoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404

Cited by (487)

Items 201–300 of 487

1. Fragmentation of the Golgi Apparatus Induced by the Overexpression of Wild-Type and Mutant Human Tau Forms in Neurons
   Dalinda Liazoghli, Sébastien Perreault, Kristina D. Micheva, Mylène Desjardins, Nicole M. Leclerc · 2005 · American Journal Of Pathology
2. High–Molecular-Weight Paired Helical Filaments from Alzheimer Brain Induces Seeding of Wild-Type Mouse Tau into an Argyrophilic 4R Tau Pathology in Vivo
   Emilie Audouard, Sarah Houben, Caterina Masaracchia, Zehra Yilmaz, Valérie Suain, Michèle Authelet, Robert De Decker, Luc Buée, Alain Boom, Karelle Leroy et al. · 2016 · American Journal Of Pathology
3. Rapamycin Ester Analog CCI-779/Temsirolimus Alleviates Tau Pathology and Improves Motor Deficit in Mutant Tau Transgenic Mice
   Christelle Frédérick, Kunié Ando, Karelle Leroy, Céline Héraud, Valérie Suain, Luc Buée, Jean‐Pierre Brion · 2015 · Journal of Alzheimer s Disease
4. Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology.
   R. Shiurba, K. Ishiguro, Miho Takahashi, Kazuki Sato, E. T. Spooner, M. Mercken, Rie Yoshida, T. R. Wheelock, H. Yanagawa, K. Imahori et al. · 1996 · Brain Research
5. Neuronal activity and early neurofibrillary tangles in Alzheimer's disease
   Kimmo J. Hatanpaa, Daniel R. Brady, James Stoll, Stanley Isaac Rapoport, Krish Chandrasekaran · 1996 · Annals of Neurology
6. Postmortem changes in the phosphorylation state of tau-protein in the rat brain
   Ulrich Gärtner, Carsten Janke, Max Holzer, Eugeen Vanmechelen, Thomas Arendt · 1998 · Neurobiology of Aging
7. Assessments of the accumulation severities of amyloid β-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains
   Xinwen Zhou, Xu Li, Cecilia Björkdahl, Magnus J.C. Sjögren, Irina I. Alafuzoff, Hilkka S. Soininen, Inge Grundke, Khalid Iqbal, Bengt G. Winblad, Jin-Jing Pei · 2006 · Neurobiology of Disease
8. Mitotic phosphorylation of tau protein in neuronal cell lines resembles phosphorylation in Alzheimer's disease
   Ute Preuß, Eva‐Maria Mandelkow · 1998 · European Journal of Cell Biology
9. The interrelationship between selective tau phosphorylation and microtubule association
   Han‐qing Xie, Joel M. Litersky, Judith A. Hartigan, Richard Scott Jope, Gail V.W. Johnson · 1998 · Brain Research
10. Bimodal modulation of tau protein phosphorylation and conformation by extracellular Zn2+ in human-tau transfected cells
    Alain Boom, Michèle Authelet, Robert Dedecker, Christelle Frédérick, Roxane Van Heurck, Valéry Daubie, Karelle Leroy, Roland Pochet, Jean‐Pierre Brion · 2008 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
11. Semi-Automated Digital Image Analysis of Pick’s Disease and TDP-43 Proteinopathy
    David John Irwin, Matthew D. Byrne, Corey T. McMillan, Felicia Ilyssa Cooper, Steven Edward Arnold, Edward B. Lee, Vivianna M. Van Deerlin, Sharon Xiangwen Xie, Virginia M.‐Y. Lee, Murray Grossman et al. · 2015 · Journal of Histochemistry & Cytochemistry
12. β-Amyloid Induces Pathology-Related Patterns of Tau Hyperphosphorylation at Synaptic Terminals
    Hsin‐Yi Wu, Po-Cheng Kuo, Yi-Ting Wang, Hao-Tai Lin, Allyson D. Roe, Bo Y. Wang, Chia‐Li Han, Bradley T. Hyman, Yu‐Ju Chen, Hwan‐Ching Tai · 2018 · Journal of Neuropathology & Experimental Neurology
13. Modulation of tau phosphorylation and intracellular localization by cellular stress
    Scott M. Jenkins, Marcus ZINNERMAN, Craig Curtis Garner, Gail V.W. Johnson · 2000 · Biochemical Journal
14. Microtubule‐associated protein tau in human prostate cancer cells: Isoforms, phosphorylation, and interactions
    Skye Souter, Gloria S. Lee · 2009 · Journal of Cellular Biochemistry
15. Split GFP complementation assay: a novel approach to quantitatively measure aggregation of tau in situ: effects of GSK3β activation and caspase 3 cleavage
    Wanjoo Chun, G. S. Waldo, Gail V.W. Johnson · 2007 · Journal of Neurochemistry
16. Phosphorylated tau/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus
    Sunil V. Patel, Edward B. Lee, Sharon Xiangwen Xie, Anica C. Law, Eric M. Jackson, Steven Edward Arnold, Christopher M. Clark, Leslie M. J. Shaw, Michael Sean Grady, John Q. Trojanowski et al. · 2012 · Fluids and Barriers of the CNS
17. Presence of a carboxy-terminal pseudorepeat and disease-like pseudohyperphosphorylation critically influence tau’s interaction with microtubules in axon-like processes
    Benedikt Niewidok, Maxim Igaev, Frederik Sündermann, Dennis Janning, Lidia Bakota, Roland Brandt · 2016 · Molecular Biology of the Cell
18. Comparative distribution of tau phosphorylated at Ser262 in pre-tangles and tangles
    Jane Lauckner, Peter Frey, Changiz Geula · 2003 · Neurobiology of Aging
19. Progressive Reduction of Synaptophysin Message in Single Neurons in Alzheimer Disease
    Linda M. Callahan, William A. Vaules, Paul D. Coleman · 2002 · Journal of Neuropathology & Experimental Neurology
20. Pathological tau and reactive astrogliosis are associated with distinct functional deficits in a mouse model of tauopathy
    Henika Patel, Pablo Martínez, Abigail Perkins, Xavier Taylor, Nur Jury, David L. McKinzie, Cristian A. Lasagna‐Reeves · 2021 · Neurobiology of Aging
21. Cellular factors modulating the mechanism of tau protein aggregation
    Sarah N. Fontaine, Jonathan J. Sabbagh, Jeremy D. Baker, Carlos R. Martinez Licha, April L. Darling, Chad A. Dickey · 2015 · Cellular and Molecular Life Sciences
22. Blocking the apolipoprotein E/Amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology
    Liu, Shan, Breitbart, Ariel, Sun, Yanjie, Mehta, Pankaj D., Boutajangout, Allal, Scholtzova, Henrieta, Wisniewski, Thomas · 2014 · Journal of Neurochemistry
23. Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models
    Christopher M. Acker, Stefanie K. Forest, Ray Zinkowski, Peter Davies, Cristina d’Abramo · 2012 · Neurobiology of Aging
24. Comparative survey of the topographical distribution of signature molecular lesions in major neurodegenerative diseases
    Steven Edward Arnold, Jon B. Toledo, Dina H. Appleby, Sharon Xiangwen Xie, Weixin Wang, Young Baek, David A. Wolk, Edward B. Lee, Bruce L. Miller, Virginia M.‐Y. Lee et al. · 2013 · The Journal of Comparative Neurology
25. In Vivo Turnover of Tau and APP Metabolites in the Brains of Wild-Type and Tg2576 Mice: Greater Stability of sAPP in the β-Amyloid Depositing Mice
    José Morales‐Corraliza, Matthew J. Mazzella, Jason D. Berger, Nicole S. Diaz, Jennifer H. K. Choi, Efrat Levy, Yasuji Matsuoka, Emmanuel Planel, Paul M. Mathews · 2009 · PLoS ONE
26. Molecular analysis of mutant and wild-type tau deposited in the brain affected by the FTDP-17 R406W mutation.
    T. Miyasaka, M. Morishima-kawashima, R. Ravid, P. Heutink, J. V. van Swieten, Kazuo Nagashima, Yasuo Ihara · 2001 · American Journal of Pathology
27. Conformational changes and cleavage of tau in Pick bodies parallel the early processing of tau found in Alzheimer pathology
    Siddhartha Mondragón‐Rodríguez, R. Mena, Lester I. Binder, Mark A. Smith, George L. Perry, Francisco García‐Sierra · 2007 · Neuropathology and Applied Neurobiology
28. HIV-1 Tat contributes to Alzheimer's disease-like pathology in PSAPP mice.
    Brian N. Giunta, Houyan Hou, Yuyan Zhu, Elona Rrapo, Jun Tian, Takashi Mori, Deborah Commins, Elyse J. Singer, Johnny J. He, Francisco Fernandez et al. · 2009 · PubMed Central
29. Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer’s disease
    Vanesa R. Hyde, Chaoming Zhou, J R Muñóz y Fernández, Krishnashis Chatterjee, Pururav Ramakrishna, Amanda Lin, Gregory W. Fisher, Orhan T. Celiker, Jill Caldwell, Omer Bender et al. · 2025 · Cell Reports
30. The neurotoxicity of amyloid β-protein oligomers is reversible in a primary neuron model
    Daisuke Tanokashira, Naomi Mamada, Fumiko Yamamoto, Kaori Taniguchi, Akira Tamaoka, Madepalli Krishnappa Lakshmana, Wataru Araki · 2017 · Molecular Brain
31. Morphological and Biochemical Correlations of Abnormal Tau Filaments in Progressive Supranuclear Palsy
    Takahashi, Makio, Weidenheim, Karen M., Dickson, Dennis W., Ksiezak-Reding, Hanna · 2002 · Journal of Neuropathology & Experimental Neurology
32. Luminescent Conjugated Oligothiophenes for Sensitive Fluorescent Assignment of Protein Inclusion Bodies
    Therése Klingstedt, Cristiane Blechschmidt, Anna Nogalska, Stefan Prokop, Bo Häggqvist, Olof Danielsson, W. King Engel, Valerie Askanas, Frank L. Heppner, K. Peter R. Nilsson · 2013 · ChemBioChem
33. The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies
    Diane P. Hanger, Graham Gibb, Rohan de Silva, Allal Boutajangout, Jean‐Pierre Brion, Tamás Révész, Andrew J. Lees, Brian H. Anderton · 2002 · FEBS Letters
34. Spinal Cord Neurofibrillary Pathology in Alzheimer Disease and Guam Parkinsonism-Dementia Complex
    Marie Luise Schmidt, Victoria A. Zhukareva, Daniel P. Perl, Shelley K. Sheridan, Theresa Schuck, Virginia M.‐Y. Lee, John Q. Trojanowski · 2001 · Journal of Neuropathology & Experimental Neurology
35. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration
    Tetsuaki Arai, Kenji Ikeda, Haruhiko Akiyama, Kuniaki Tsuchiya, Shuji Iritani, Koichi Ishiguro, Saburo Yagishita, Tatsuro Oda, Toshinari Odawara, Eizo Iseki · 2003 · Acta Neuropathologica
36. Extracellular Vesicles Isolated from Familial Alzheimer’s Disease Neuronal Cultures Induce Aberrant Tau Phosphorylation in the Wild-Type Mouse Brain
    Brent D. Aulston, Qing Liu, Michael Mante, Jazmin B. Florio, Robert A. Rissman, Shauna H. Yuan · 2019 · Journal of Alzheimer s Disease
37. Tau phosphorylation in a mouse model of temporal lobe epilepsy.
    Alves, Marianna, Kenny, Aidan, de Leo, Gioacchino, Beamer, Edward H., Engel, Tobias · 2019 · Frontiers in Aging Neuroscience
38. A combinatorial native MS and LC-MS/MS approach reveals high intrinsic phosphorylation of human Tau but minimal levels of other key modifications
    Friedel Drepper, Jacek Biernat, Senthilvelrajan Kaniyappan, Helmut E. Meyer, Eva‐Maria Mandelkow, Bettina Warscheid, Eckhard Mandelkow� · 2020 · Journal of Biological Chemistry
39. Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau
    Kevin H. Strang, Marshall S. Goodwin, Cara J. Riffe, Brenda D. Moore, Paramita Chakrabarty, Yona Levites, Todd Eliot Golde, Benoit I. Giasson · 2017 · Acta Neuropathologica Communications
40. Ultrastructural instability of paired helical filaments from corticobasal degeneration as examined by scanning transmission electron microscopy.
    Hanna Ksiȩżak-Reding, Elzbieta Tracz, Lixin Yang, Dennis W. Dickson, Martha N. Simon, J.S. Wall · 1996 · Europe PMC (PubMed Central)
41. PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis
    Ravi Shankar Akundi, Lianteng Zhi, Hansruedi Büeler · 2011 · Neurobiology of Disease
42. Mutant (R406W) Human Tau Is Hyperphosphorylated and Does Not Efficiently Bind Microtubules in a Neuronal Cortical Cell Model
    Pavan Krishnamurthy, Gail V.W. Johnson · 2004 · Journal of Biological Chemistry
43. Multifunctional Effect of Human Serum Albumin Reduces Alzheimer’s Disease Related Pathologies in the 3xTg Mouse Model
    Assaf Ezra, Inna Rabinovich-Nikitin, Polina Rabinovich‐Toidman, Beka Solomon · 2016 · Journal of Alzheimer s Disease
44. Immunomodulation Targeting Abnormal Protein Conformation Reduces Pathology in a Mouse Model of Alzheimer's Disease
    Fernando Goñi, Frances Prelli, Yong Ji, Henrieta Scholtzova, Jing Yang, Yanjie Sun, Feng‐Xia Liang, Regina Kascsak, Richard J. Kascsak, Pankaj D Mehta et al. · 2010 · PLoS ONE
45. Genetic and neuroanatomic associations in sporadic frontotemporal lobar degeneration
    Corey T. McMillan, Jon B. Toledo, Brian Avants, Philip A. Cook, Elisabeth McCarty Wood, EunRan R. Suh, David John Irwin, John Powers, Christopher A. Olm, Lauren B. Elman et al. · 2013 · Neurobiology of Aging
46. Tau Protein Is Hyperphosphorylated in a Site‐Specific Manner in Apoptotic Neuronal PC12 Cells
    Jianwen Zhang, Gail V. W. Johnson · 2000 · Journal of Neurochemistry
47. Structures of AT8 and PHF1 phosphomimetic tau: Insights into the posttranslational modification code of tau aggregation
    Nadia El Mammeri, Aurelio James Dregni, Pu Duan, Mei Hong · 2024 · Proceedings of the National Academy of Sciences
48. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy
    Omi Katsuse, Eizo Iseki, Tetsuaki Arai, Haruhiko Akiyama, Takashi Togo, Hirotake Uchikado, Masanori Kato, Rohan de Silva, Andrew John Lees, Kenji Kosaka · 2003 · Acta Neuropathologica
49. Glycogen synthase kinase-3β and the p25 activator of cyclin dependent kinase 5 increase pausing of mitochondria in neurons
    Morel, M., Authelet, M., Dedecker, R., Brion, J.P. · 2010 · Neuroscience
50. Regulation of Tau Phosphorylation in Alzheimer's Disease
    Virginia M.‐Y. Lee · 1996 · Annals of the New York Academy of Sciences
51. Diaminothiazoles Modify Tau Phosphorylation and Improve the Tauopathy in Mouse Models*
    Xuemei Zhang, Israel Hernández, Damien Rei, Waltraud Mair, Joydev K. Laha, Madison E. Cornwell, Gregory D. Cuny, Li‐Huei Tsai, Judith A. J. Steen, Kenneth S. Kosik · 2013 · Journal of Biological Chemistry
52. Mitophagy Failure in APP and Tau Overexpression Model of Alzheimer’s Disease
    Patricia Martín-Maestro, Ricardo Gargini, Esther García, Diana Simón, Jesús Ávila, Vega García‐Escudero · 2019 · Journal of Alzheimer s Disease
53. Hyperphosphorylated protein tau is restricted to neurons devoid of perineuronal nets in the cortex of aged bison⋆
    W Härtig · 2001 · Neurobiology of Aging
54. Unbiased screen reveals ubiquilin-1 and -2 highly associated with huntingtin inclusions
    Nicola J. Rutherford, Jada M. Lewis, Amy K. Clippinger, Michael A. Thomas, Jennifer L. Adamson, Pedro E. Cruz, Ashley D. Cannon, Guilian M. Xu, Todd Eliot Golde, Gerry Shaw et al. · 2013 · Brain Research
55. Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
    Garrett S. Gibbons, Soojung Kim, John L. Robinson, Lakshmi N. Changolkar, David John Irwin, Leslie M. J. Shaw, Virginia M.‐Y. Lee, John Q. Trojanowski · 2019 · Acta Neuropathologica Communications
56. Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative Phenotypes
    Marshall S. Goodwin, Olga Sinyavskaya, Franklin Burg, Veronica O’Neal, Carolina Ceballos‐Diaz, Pedro E. Cruz, Jada M. Lewis, Benoit I. Giasson, Peter Davies, Todd Eliot Golde et al. · 2020 · Molecular Therapy
57. An update on the association between traumatic brain injury and Alzheimer’s disease: Focus on Tau pathology and synaptic dysfunction
    Liangping Li, Jiawen Liang, Hongjun Fu · 2020 · Neuroscience & Biobehavioral Reviews
58. Inhibition of protein phosphatase-2B (calcineurin) activity towards Alzheimer abnormally phosphorylated τ by neuroleptics
    Cheng‐Xin Gong, SadiaS. Shaikh, Inge Grundke, Khalid Iqbal · 1996 · Brain Research
59. Formation of diffuse and fibrillar tangles in aging and early Alzheimer’s disease☆
    N.V Uboga, Joseph L. Price · 2000 · Neurobiology of Aging
60. Immunomodulation targeting of both Aβ and tau pathological conformers ameliorates Alzheimer’s disease pathology in TgSwDI and 3xTg mouse models
    Goñi, Fernando, Herline, Krystal, Peyser, Daniel, Wong, Kinlung, Ji, Yong, Sun, Yanjie, Mehta, Pankaj, Wisniewski, Thomas · 2013 · Journal of Neuroinflammation
61. Levels of kinesin light chain and dynein intermediate chain are reduced in the frontal cortex in Alzheimer’s disease: implications for axoplasmic transport
    Marina Morel, Céline Héraud, Charles Nicaise, Valérie Suain, Jean‐Pierre Brion · 2011 · Acta Neuropathologica
62. Kinase–Kinase Interaction and Modulation of Tau Phosphorylation
    Mitsuko Hashiguchi, Toshio Hashiguchi · 2012 · International review of cytology
63. Picalm reduction exacerbates tau pathology in a murine tauopathy model
    Kunié Ando, Robert De Decker, Cristina Vergara, Zehra Yilmaz, Salwa Mansour, Valérie Suain, Kristel Sleegers, Marie-Ange de Fisenne, Sarah Houben, Marie‐Claude Potier et al. · 2020 · Acta Neuropathologica
64. Downstream effects of polypathology on neurodegeneration of medial temporal lobe subregions
    Laura E.M. Wisse, Sadhana Ravikumar, Ranjit Ittyerah, Sydney Lim, J. Lane, Madigan L. Bedard, Long Xie, Sandhitsu R. Das, Theresa Schuck, Murray Grossman et al. · 2021 · Acta Neuropathologica Communications
65. Progressive supranuclear palsy and tau hyperphosphorylation in a patient with a C212Y parkin mutation
    Marina P. Sánchez, Isabel Gonzalo, Jesús Ávila, Justo Garcı́a de Yébenes · 2002 · Journal of Alzheimer s Disease
66. Microtubule destruction induces tau liberation and its subsequent phosphorylation
    Miyasaka, Tomohiro, Sato, Sinji, Tatebayashi, Yoshitaka, Takashima, Akihiko · 2010 · FEBS Letters
67. Different Susceptibility to Neurodegeneration of Dorsal and Ventral Hippocampal Dentate Gyrus: A Study with Transgenic Mice Overexpressing GSK3β
    Almudena Fuster-Matanzo, Marı́a Llorens-Martı́n, Elena Gómez de Barreda, Jesús Ávila, Félix Hernández · 2011 · PLoS ONE
68. A new case of frontotemporal dementia and parkinsonism resulting from an intron 10 +3‐splice site mutation in the tau gene: clinical and pathological features
    Markus Tolnay, Maria Grazia Spillantini, Claudia Rizzini, Diana Eccles, James S Lowe, David H. Ellison · 2000 · Neuropathology and Applied Neurobiology
69. A Noncatalytic Domain of Glycogen Synthase Kinase-3 (GSK-3) Is Essential for Activity
    Jessica L. Buescher, Christopher J. Phiel · 2010 · Journal of Biological Chemistry
70. Increased tau phosphorylation but absence of formation of neurofibrillary tangles in mice double transgenic for human tau and Alzheimer mutant (M146L) presenilin-1
    Allal Boutajangout, Karelle Leroy, Nathalie Touchet, M. Authelet, V. Blanchard, Günter L. Tremp, Laurent Pradier, Jean‐Pierre Brion · 2002 · Neuroscience Letters
71. Staging of Alzheimer's Pathology in Triple Transgenic Mice: A Light and Electron Microscopic Analysis
    Oh, Kwang-Jin, Perez, Sylvia E., Lagalwar, Sarita, Vana, Laurel, Binder, Lester, Mufson, Elliott J. · 2010 · International Journal of Alzheimer's Disease
72. Calpastatin, an endogenous calpain-inhibitor protein, regulates the cleavage of the Cdk5 activator p35 to p25
    Ko Sato, Seiji Minegishi, Jiro Takano, Florian Plattner, Taro Saito, Akiko Asada, Hiroyuki Kawahara, Nobuhisa Iwata, Takaomi C. Saido, Shin‐ichi Hisanaga · 2011 · Journal of Neurochemistry
73. Knockin’ on heaven’s door: Molecular mechanisms of neuronal tau uptake
    Samantha De La‐Rocque, Edoardo Moretto, Ioana Butnaru, Giampietro Schiavo · 2020 · Journal of Neurochemistry
74. Activation of Glycogen Synthase Kinase 3β Promotes the Intermolecular Association of Tau
    Wanjoo Chun, Gail V.W. Johnson · 2007 · Journal of Biological Chemistry
75. Parallel Compensatory and Pathological Events Associated with Tau Pathology in Middle Aged Individuals with Down Syndrome
    Elizabeth Head, Ira T. Lott, Patrick R. Hof, Constantin Bouras, J. Su, R. Kim, Richard J. Haier, Carl W. Cotman · 2003 · Journal of Neuropathology & Experimental Neurology
76. Semaphorin 3C preserves survival and induces neuritogenesis of cerebellar granule neurons in culture
    María Teresa Moreno-Flores, Ester Martı́n-Aparicio, María Jesús Martín‐Bermejo, Marta Agudo‐Barriuso, Stephen Brendan McMahon, Jesús Ávila, Javier Díaz‐Nido, Francisco G. Wandosell · 2003 · Journal of Neurochemistry
77. Molecular Pathology of Alzheimer’s Disease and Related Disorders
    Stephen D. Ginsberg, Marie Luise Schmidt, Peter B. Crino, James H. Eberwine, Virginia M.‐Y. Lee, John Q. Trojanowski · 1999 · Cerebral cortex
78. GSK-3 dependent phosphoepitopes recognized by PHF-1 and AT-8 antibodies are present in different tau isoforms
    HERNANDEZ, F · 2003 · Neurobiology of Aging
79. α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies
    Francisco Javier Padilla-Godínez, Eunice Ruth Vázquez-García, María Isabel Trujillo-Villagrán, Luis Oskar Soto-Rojas, Marcela Palomero‐Rivero, Omar Hernández-González, Francisco Pérez-Eugenio, Omar Collazo-Navarrete, Óscar Arias-Carrión, Magdalena Guerra‐Crespo · 2025 · Frontiers in Neuroscience
80. Sodium tungstate decreases the phosphorylation of tau through GSK3 inactivation
    Alberto Gómez‐Ramos, Jorge E. Domínguez, Delia Zafra, Helena Corominola, Ramón Gomis, Joan Josep Guinovart, Jesús Ávila · 2006 · Journal of Neuroscience Research
81. Tau in MAPK Activation
    Chad J. Leugers, Ju Yong Koh, Willis Hong, Gloria S. Lee · 2013 · Frontiers in Neurology
82. Molecular targets of lithium action
    Bàrbara Corbella, Eduard Vieta · 2003 · Acta Neuropsychiatrica
83. Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy
    Benoit I. Giasson, Meghann E. Mabon, John E. Duda, Thomas Jude Montine, David Robertson, Howard I. Hurtig, Virginia M.‐Y. Lee, John Q. Trojanowski · 2003 · Acta Neuropathologica
84. Immunotherapy for Tauopathies
    Jiaping Gu, Einar M. Sigurdsson · 2011 · Journal of Molecular Neuroscience
85. Differential effects of voluntary treadmill exercise and caloric restriction on tau pathogenesis in a mouse model of Alzheimer's disease-like tau pathology fed with Western diet
    Maud Gratuze, Jacinthe Julien, Françoise Morin, André Marette, Emmanuel Planel · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
86. Microglia changes associated to Alzheimer's disease pathology in aged chimpanzees
    Melissa K. Edler, Chet C. Sherwood, Richard S. Meindl, Emily L. Munger, William Donald Hopkins, John J. Ely, JOSEPH M. ERWIN, Daniel P. Perl, Elliott Jay Mufson, Patrick R. Hof et al. · 2018 · The Journal of Comparative Neurology
87. HSF1 physically neutralizes amyloid oligomers to empower overgrowth and bestow neuroprotection
    Zijian Tang, Kuo‐Hui Su, Meng Xu, Chengkai Dai · 2020 · Science Advances
88. Ubiquitin is Associated with Early Truncation of Tau Protein at Aspartic Acid421 during the Maturation of Neurofibrillary Tangles in Alzheimer's Disease
    Francisco García‐Sierra, José Jaime Jarero-Basulto, Zdena Krištofíková, Emerich Majer, Lester I. Binder, Daniela Řı́pová · 2011 · Brain Pathology
89. Dexmedetomidine increases tau phosphorylation under normothermic conditions in vivo and in vitro
    Robert A. Whittington, László Virág, Maud Gratuze, Franck R. Petry, Anastasia Noël, Isabelle Poitras, Geoffrey Truchetti, François Marcouiller, Marie-Amélie Papon, Noura B. El Khoury et al. · 2015 · Neurobiology of Aging
90. Usp14 Deficiency Increases Tau Phosphorylation without Altering Tau Degradation or Causing Tau-Dependent Deficits
    Youngnam N. Jin, Ping‐Chung Chen, Jennifer A. Watson, Brandon J. Walters, Scott E. Phillips, Karen Green, Robert E. Schmidt, Julie A. Wilson, Gail V.W. Johnson, Erik D. Roberson et al. · 2012 · PLoS ONE
91. PKA Phosphorylations on Tau: Developmental Studies in the Mouse
    Cathy A. Andorfer, Peter Davies · 2000 · Developmental Neuroscience
92. Site-specific regulation of Alzheimer-like tau phosphorylation in living neurons
    Michelle A. Burack, Shelley Halpain · 1996 · Neuroscience
93. Activation of mitogen-activated protein kinase cascade and phosphorylation of cytoskeletal proteins after neurone-specific activation of p21ras. II. Cytoskeletal proteins and dendritic morphology
    Max Holzer, L. Rödel, Gudrun Seeger, Ulrich Gärtner, Frank Narz, Carsten Janke, Rolf Heumann, Thomas Arendt · 2001 · Neuroscience
94. c‐jun N‐terminal kinase hyperphosphorylates R406W tau at the PHF‐1 site during mitosis
    Yoshitaka Tatebayashi, Emmanuel Planel, Dehua Chui, Shinji Sato, Tomohiro Miyasaka, Naruhiko Sahara, Miyuki Murayama, Naomi Kikuchi, Katsuji Yoshioka, Ravid Rivka et al. · 2006 · The FASEB Journal
95. Adrenomedullin Contributes to Age-Related Memory Loss in Mice and Is Elevated in Aging Human Brains
    Ignacio M. Larráyoz, Hilda Ferrero, Eva Martišová, Francisco Javier Gil-Bea, María Javier Ramírez, Alfredo Martı́nez · 2017 · Frontiers in Molecular Neuroscience
96. Non-invasive, in vivo monitoring of neuronal transport impairment in a mouse model of tauopathy using MEMRI
    Anne Bertrand, Umer Khan, Dung Minh Hoang, Dmitry S. Novikov, Pavan Krishnamurthy, Hameetha Banu Rajamohamed Sait, Benjamin W. Little, Einar M. Sigurdsson, Youssef Zaim Wadghiri · 2012 · NeuroImage
97. Cultured cell and transgenic mouse models for tau pathology linked to β-amyloid
    George S. Bloom, Ke Ren, Charles G. Glabe · 2004 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
98. Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model
    Bailey, Rachel M, Howard, John, Knight, Joshua, Sahara, Naruhiko, Dickson, Dennis W, Lewis, Jada · 2014 · Molecular Neurodegeneration
99. Hyperphosphorylated Human Tau Accumulates at the Synapse, Localizing on Synaptic Mitochondrial Outer Membranes and Disrupting Respiration in a Mouse Model of Tauopathy
    Andrew J. Trease, Joseph W. George, Nashanthea J. Roland, Eliezer Z. Lichter, Katy M. Emanuel, Steven Totusek, Howard S. Fox, Kelly L. Stauch · 2022 · Frontiers in Molecular Neuroscience
100. Acute anoxia induces tau dephosphorylation in rat brain slices and its possible underlying mechanisms
     Rong Liu, Jin-Jing Pei, Xiaochuan Wang, Xinwen Zhou, Qing Tian, Bengt G. Winblad, Jian‐Zhi Wang · 2005 · Journal of Neurochemistry